Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Cosmo Bio Co., Ltd.
WARNING LETTER
•Cosmo Bio Co., Ltd.•January 18, 2022

Cosmo Bio Co., Ltd. – FDA Warning Letter, Jan 18, 2022

Record Details

On January 6, 2022, the FDA issued a Warning Letter to Cosmo Bio Co., Ltd. (FEI 3015297228) in Daejeon, South Korea, following a review of records submitted in response to an April 22, 2020, request. The letter identifies significant violations of Current Good Manufacturing Practice (CGMP) regulations for finished pharmaceuticals (21 CFR parts 210 and 211), rendering their drug product, Georganic Propolis Acne Care Serum, adulterated under 21 U.S.C. 351(a)(2)(B).

Key violations include: 1. Failure to conduct appropriate laboratory testing for identity and strength of active ingredients prior to drug product release (21 CFR 211.165(a)). 2. Failure to establish and follow an adequate written stability testing program to determine storage conditions and expiration dates (21 CFR 211.166(a)). 3. Failure to establish and follow adequate written procedures for cleaning and maintenance of equipment, specifically lacking cleaning validation for shared product-contact equipment (21 CFR 211.67(b)).

Furthermore, Georganic Propolis Acne Care Serum is deemed an unapproved new drug and misbranded. It is an unapproved new drug because its active ingredient, "propolis," is not

Company
Cosmo Bio Co., Ltd.
Inspection date
January 18, 2022
Product type
Drugs
Office
Center for Drug Evaluation and Research
Person
  • Francis Godwin (Director)
View Company Profile

ID · fd9bf877-c94a-453a-a395-105f88d4d6a3

Violation Codes10
21 U.S.C. 351(a)(2)(B)21 CFR 21021 CFR 21121 CFR 211.165(a)21 CFR 211.166(a)21 CFR 211.67(b)21 CFR 201.12821 CFR 201.66(b)(2)21 CFR 201.10(c)(4)FD&C Act 501(a)(2)(B)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Cosmo Bio Co., Ltd.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.